Correlation Between Puma Biotechnology and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Monopar Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Monopar Therapeutics.
Diversification Opportunities for Puma Biotechnology and Monopar Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Puma and Monopar is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Monopar Therapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 20.94 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Puma Biotechnology is 7.14 times less risky than Monopar Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 208.00 in Monopar Therapeutics on December 3, 2024 and sell it today you would earn a total of 2,885 from holding Monopar Therapeutics or generate 1387.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Monopar Therapeutics
Performance |
| Timeline |
| Puma Biotechnology |
| Monopar Therapeutics |
Puma Biotechnology and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Monopar Therapeutics
The main advantage of trading using opposite Puma Biotechnology and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |